🧪
hypothesis

VPS26A Subunit Enhancement to Stabilize Retromer Complex Assembly

Hypothesis

VPS26A Subunit Enhancement to Stabilize Retromer Complex Assembly

This hypothesis proposes that targeted enhancement of VPS26A subunit expression and stability can rescue retromer complex dysfunction by improving the structural integrity and assembly efficiency of the VPS26/VPS29/VPS35 heterotrimer.
🧬 VPS26A🩺 proteomics🎯 Composite 47%💱 $0.48▲6.7%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 5 support 6 oppose
✓ All Quality Gates Passed
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite47%

🧪 Overview

This hypothesis proposes that targeted enhancement of VPS26A subunit expression and stability can rescue retromer complex dysfunction by improving the structural integrity and assembly efficiency of the VPS26/VPS29/VPS35 heterotrimer. Unlike approaches focusing on VPS35 restoration, this strategy targets the cargo recognition subunit VPS26A, which serves as the critical interface between the retromer core and cargo-selective sorting nexins. The mechanism involves VPS26A-mediated stabilization of the entire retromer complex through enhanced protein-protein interactions at the endosomal membrane. Specifically, increased VPS26A levels would promote more robust binding between the cargo recognition domain and sorting nexin dimers (SNX1/SNX2 or SNX5/SNX6), leading to improved retrograde transport from endosomes to the trans-Golgi network. This approach addresses the fundamental assembly defects observed in neurodegenerative diseases where retromer dysfunction contributes to pathological protein accumulation. The intervention would utilize VPS26A overexpression vectors or small molecule stabilizers that enhance VPS26A folding and membrane recruitment.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["VPS35-VPS26-VPS29<br/>Retromer Core Trimer"]
    B["Endosomal Cargo Recognition<br/>CI-MPR/ATG9/SorLA Retrieval"]
    C["Retrograde Trafficking<br/>Endosome-to-TGN"]
    D["WASH Complex Recruitment<br/>Actin Branching on Endosome"]
    E["Cathepsin D Maturation<br/>Lysosomal Hydrolase Sorted"]
    F["VPS35 D620N Mutation<br/>Parkinson's PARK17"]
    G["Lysosomal Dysfunction<br/>Alpha-Synuclein Accumulation"]
    A --> B
    B --> C
    C --> D
    C --> E
    F -.->|"impairs"| A
    F --> G
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style E fill:#1b5e20,stroke:#81c784,color:#81c784
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports6 contradicts
Supports
VPS35 mutations cause autosomal-dominant Parkinson's disease with synaptic dysfunction
PMID:21725305
Supports
Retromer protein levels are reduced in AD hippocampus and correlate with cognitive decline
PMID:25898100
Supports
Retromer dysfunction causes APP mislocalization to endosomes, increasing Aβ production
PMID:23792953
Supports
R55 compound rescues VPS35 mutations and restores retromer function in cellular models
PMID:23499328
Supports
Retromer mediates retrieval of synaptic receptors (APP, Vps10, SorLA) from degradative pathway
PMID:27457933
Contradicts
VPS35 mutations cause Parkinson's, not Alzheimer's - mechanistic disconnect
PMID:21725305
Contradicts
VPS35 overexpression in mouse models causes dopamine neuron degeneration
PMID:30270026
Contradicts
Retromer enhancement increases Aβ production in some cellular models by redirecting APP to amyloidogenic compartments
PMID:27457933
Contradicts
R55 compound validation limited to HeLa cells and yeast; no human neuron data
PMID:23499328
Contradicts
Retromer affects thousands of cargo including Wntless, glutamate receptors, transferrin receptor
PMID:25898100
Contradicts
Correlation between VPS35 levels and cognitive decline may be secondary to neurodegeneration
PMID:25898100
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — VPS26A

No curated PDB or AlphaFold mapping for VPS26A yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for VPS26A from GTEx v10.

Cerebellar Hemisphere46.5 Cerebellum38.3 Spinal cord cervical c-121.2 Frontal Cortex BA917.9 Nucleus accumbens basal ganglia15.7 Substantia nigra15.0 Anterior cingulate cortex BA2414.2 Hypothalamus14.1 Caudate basal ganglia14.1 Cortex13.2 Putamen basal ganglia12.8 Hippocampus11.8 Amygdala11.6median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for VPS26A →

No DepMap CRISPR Chronos data found for VPS26A.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0135
Events (7d)
1
Price History
▲6.7%

💾 Resource Usage

LLM Tokens
39,448
$0.1183
Total Cost
$0.1183

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF VPS26A is overexpressed (2-fold above endogenous levels) in human iPSC-derived neurons via AAV-mediated transduction, THEN retromer complex assembly will increase by ≥30% (measured by co-immunoprec≥30% increase in VPS26/VPS29/VPS35 heterotrimer complex formation detected by quantitative co-immunoprecipitation— no observation —pending0.65
IF a small molecule VPS26A stabilizer (10μM, daily for 14 days) is administered to a mouse model of retromer dysfunction (Vps35 D620N knock-in), THEN mannose-6-phosphate receptor (M6PR) trafficking to≥70% restoration of M6PR colocalization with TGN46 (trans-Golgi marker) compared to wild-type controls, quantified by confocal microscopy— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF VPS26A is overexpressed (2-fold above endogenous levels) in human iPSC-derived neurons via AAV-mediated transduction, THEN retromer complex assembly will increase by ≥30% (measured by co-immunoprecipitation of VPS26/VPS29/VPS35 heterotrimer) within 7 days post-transduction.
Predicted outcome: ≥30% increase in VPS26/VPS29/VPS35 heterotrimer complex formation detected by quantitative co-immunoprecipitation
Falsification: No statistically significant increase (p>0.05) in retromer heterotrimer assembly detected by co-IP, or actual decrease in complex stability despite VPS26A overexpression
pendingconf 55%
IF a small molecule VPS26A stabilizer (10μM, daily for 14 days) is administered to a mouse model of retromer dysfunction (Vps35 D620N knock-in), THEN mannose-6-phosphate receptor (M6PR) trafficking to the trans-Golgi network will be restored to ≥70% of wild-type levels.
Predicted outcome: ≥70% restoration of M6PR colocalization with TGN46 (trans-Golgi marker) compared to wild-type controls, quantified by confocal microscopy
Falsification: M6PR trafficking remains below 50% of wild-type levels, or endosomal enlargement phenotype shows no improvement (p>0.05 by unpaired t-test), indicating complete failure of VPS26A stabilization strateg
View on SciDEX ↗